Bristow, US
Basheer N. Bristow, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20100281246 | SYNCHRONIZATION OF SWAPPABLE MODULE IN MODULAR SYSTEM - Exemplary methods, systems, and computer program product embodiments for synchronizing a swappable module between modular computer systems are provided. Each of the embodiments has dual controllers and distributed copies of states. Upon an insertion of the swappable module in a storage system, a plurality of storage components are queried, including a partner swappable module, to determine if a quorum of identification information is present. If the quorum is present, at least one of the plurality of storage components having non-matching identification information is overwritten with the identification information of the quorum. If the quorum is not present, a reset to default procedure is performed. The reset to default procedure designates at least as many storage components of the plurality of storage components with the identification information sufficient to constitute the quorum. | 11-04-2010 |
Basheer N. Bristow, Vail, AZ US
Patent application number | Description | Published |
---|---|---|
20100064164 | Autonomic Component Service State Management for a Multiple Function Component - A mechanism is provided for autonomic component service state management for a multiple function component. The mechanism determines whether independent functions within a multiple function service boundary can be serviced. When a single function experiences a failure that requires service, repair, or replacement, the surviving functions notify the service management software of the state of the independent functions. The service management software then determines the state of the overall component and implements the appropriate service method. | 03-11-2010 |
20100238037 | ALERT PROTOCOL FOR INDICATING A FAILURE CONDITION IN A DISTRIBUTED SYSTEM - A method is disclosed to alert a system administrator of a failure condition within a distributed system having a chassis, a management module, and one or more devices installed in the chassis. Such a method may initially identify whether a device within the chassis has encountered a failure condition. The method may then determine whether the device requires removal from the chassis based on the failure condition. The method may cause a visual fault indicator associated with the device to assume a first illuminated state in the event the device requires removal. The method may cause the visual fault indicator to assume a second illuminated state in the event the device does not require removal. If communication with a management module is possible, a visual fault indicator on the chassis may assume a third illuminated state if the device requires removal. A corresponding apparatus and computer-program product are also disclosed. | 09-23-2010 |
20120030272 | Uploading and Executing Command Line Scripts - A mechanism is provided for a non-root-level user to execute command line script files via a generic command line interface. A command line interface in the data processing system receives a shellscript command from a non-root-level user via a client system. A security module in the data processing system determines whether the non-root-level user is logged on at a command line interface shell level access. Responsive to the non-root-level user being logged on at the command line interface shell level access, a storage controller at the request of a command line interface identifies a script file associated the shellscript command in a storage of the data processing system. The storage controller executes the script file and the command line interface sends the results of the execution of the script file to the non-root-level user via the client system. | 02-02-2012 |
20130179415 | Reducing Duplicate Information when Reporting System Incidents - A mechanism is provided for reducing duplicate information. Diagnostic data associated with a new incident that has occurred is received and at least one new incident dump file is created for the new incident that includes some or all of the diagnostic data. The diagnostic data in the at least one new incident dump file is compared to diagnostic data in at least one corresponding preceding incident dump file. Responsive to the at least one new incident dump file comprising diagnostic data that is different from the at least one corresponding preceding incident dump file, at least one comparison dump file is generated that comprises only the differences in the at least one new incident dump file that are not contained in the at least one corresponding preceding incident dump file. A report package that includes the at least one comparison dump file is then transmitted to a support system. | 07-11-2013 |
Brandon Eugene Bristow, Kernersville, NC US
Patent application number | Description | Published |
---|---|---|
20150371737 | TWISTED PAIR CABLE WITH SHIELDING ARRANGEMENT - A cable includes an insulative main jacket, a main conductive shield and a plurality of subunits. The main conductive shield may be located on an inner side of the insulative main jacket so as to be at least partially surrounded by the insulative main jacket. Each subunit includes a twisted pair of insulated conductors, a conductive subunit shield and a subunit insulative layer. The conductive subunit shield may at least partially surround the twisted pair of insulated conductors. The subunit insulative layer may be located on an outer side of the conductive subunit shield to at least partially surround the conductive subunit shield and the twisted pair of insulated conductors. | 12-24-2015 |
Calvin Bristow, Simpsonville, SC US
Patent application number | Description | Published |
---|---|---|
20120068440 | RETAINING MEANS FOR AN AIRBAG ARRANGEMENT AND AIRBAG ARRANGEMENT - A retention device for an airbag arrangement can include a first retaining element, which can be connected via a first end section to an airbag flap and via a second end section to a firing channel or via a first end section to at least one airbag flap and via a second end section to a carrier which encloses the airbag flap and has at least one section disposed between the first and the second end sections. The first end section and/or the second end section have at least two overlapping end subsections, which are connected to one another and which are connected opposite to one another and spaced apart from one another to the first plate and second plate, respectively. | 03-22-2012 |
Christopher A. Bristow, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20160058759 | GLUTAMINASE INHIBITOR THERAPY - Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject. | 03-03-2016 |
Cynthia L. Bristow, Dix Hills, NY US
Patent application number | Description | Published |
---|---|---|
20130017601 | MODULATION OF PLASMA MEMBRANE HUMAN LEUKOCYTE ELASTASE - A method for modulation of plasma membrane associated Human Leukocyte Elastase (HLE) to inflammatory states by interaction of HLE with an antagonist to inhibit HLE and thereby interruption in plasma associated events (e.g. HIV disease progression, bacterial infections and autoimmune diseases), which are responsive/sensitive to such inflammation. The antagonist suitable for use in this invention is designed to interact with each of the catalytic triad of the HLE plasma membranes protein and the lipid interactive amino acids of the HLE plasma membrane protein. | 01-17-2013 |
20130023472 | LDL QUANTITATION AND METHOD OF USE - The present invention features, in certain aspects, methods of promoting endocytosis of LDL with α1PI or peptides derived from α1PI. The present invention also provides methods for decreasing LDL levels in response to α | 01-24-2013 |
Cynthia L. Bristow, Roslyn, NY US
Patent application number | Description | Published |
---|---|---|
20100029558 | Alpha1 proteinase inhibitor peptides methods and use - The invention is directed to the use of peptides that can bind and block the interaction of α1 proteinase inhibitor (α | 02-04-2010 |
Cynthia L. Bristow, Long Beach, NY US
Patent application number | Description | Published |
---|---|---|
20140322741 | Cell Free CD4 Quantitation and Methods of Use - The present invention provides a low-cost cell-free assay, the α-test, that provides point-of-care CD4 enumeration using a single platform assay thereby eliminating the need for high-end instrumentation, calibrated pipetting, and specialized technical training. The number of CD4 T cells in blood is driven by the concentration of the protein α1 proteinase inhibitor (α1PI, α1 antitrypsin, serpin A1). The invention features, in part, methods for determining the number of CD4+ T cells in a sample comprising determining the concentration of alpha 1 proteinase inhibitor (α1PI) in a sample; wherein the number of CD4+ T-cells is related to the concentration of α1PI. | 10-30-2014 |
Cynthia L. Bristow, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120172286 | THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS - A previously unrecognized fundamental property of α | 07-05-2012 |
20130022991 | CELL FREE CD4 QUANTITATION AND METHODS OF USE - The present invention provides a low-cost cell-free assay, the α-test, that provides point-of-care CD4 enumeration using a single platform assay thereby eliminating the need for high-end instrumentation, calibrated pipetting, and specialized technical training. The number of CD4 T cells in blood is driven by the concentration of the protein α1proteinase inhibitor (α1PI, α1antitrypsin, serpin A1). The invention features, in part, methods for determining the number of CD4+ T cells in a sample comprising determining the concentration of alpha 1 proteinase inhibitor (α1PI) in a sample; wherein the number of CD4+ T-cells is related to the concentration of α1PI. | 01-24-2013 |
20140005108 | METHOD FOR DECREASING LOW DENSITY LIPOPROTEIN LEVELS | 01-02-2014 |
20150011479 | Alpha1 proteinase inhibitor peptides methods and use - The invention is directed to the use of peptides that can bind and block the interaction of α1 proteinase inhibitor (α | 01-08-2015 |
David Bristow, Bainbridge Island, WA US
Patent application number | Description | Published |
---|---|---|
20110314377 | AUTOMATIC HIERARCHICAL CATEGORIZATION OF MUSIC BY METADATA - A method, performed by software executing on the processor of a portable music playback device, that automatically files tracks according to hierarchical structure of categories to organize tracks in a logical order. A user interface is utilized to change the hierarchy, view track names, and select tracks for playback or other operations. The user interface uses an overlapping hierarchy of categories. A song title can be accessed in multiple different ways by starting with different categories. A preferred embodiment of the invention uses the top-level categories “Albums”, “Artists”, “Genres” (or styles), and “Play Lists”. Within the Albums category are names of different albums of songs stored in the device. Within each album are the album tracks, or songs, associated with that album. Navigation is performed by presenting a sequence of display screens for each level of the hierarchy. | 12-22-2011 |
Duke K. Bristow, Sherman Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20110250287 | One step removal of selected molecules from body fluid and tissue - A method for reducing the number of selected antibodies in a subject's blood, the method comprising removing blood from the subject, passing the blood along an enclosed pathway, wherein the pathway comprises one or more semi-permeable hollow fibers with one or more membranes having surfaces positioned substantially perpendicular to the length of the one or more hollow fiber and antigens specific for the antibodies immobilized on the one or more membranes, returning the treated blood to the internal circulation of the subject, wherein the returned treated blood has a reduced number of selected antibodies compared to before treatment. | 10-13-2011 |
James Christhoper Bristow, North Palm Beach, FL US
Patent application number | Description | Published |
---|---|---|
20130097162 | Method and system for generating and presenting search results that are based on location-based information from social networks, media, the internet, and/or actual on-site location - Method and system for generating and presenting search results that are based on location-based information from social networks, media, the internet, and/or actual on-site location. | 04-18-2013 |
James F. Bristow, Sugar Land, TX US
Patent application number | Description | Published |
---|---|---|
20100122847 | METHODS FOR VISUALIZING DISTANCES BETWEEN WELLBORE AND FORMATION BOUNDARIES - A method for displaying a formation model while drilling a wellbore in the formation includes operating a well logging instrument at a measurement point in the formation along a wellbore while the wellbore is being drilled. Measurement data regarding the formation are obtained from the well logging instrument. An actual orientation of a geological structure is determined from the measurement data. A trajectory of the wellbore is displayed in three dimensions as it is being drilled through the formation. While drilling the wellbore, the geological structure is displayed along the trajectory of the wellbore according to the determined actual orientation of the geological structure. The actual orientation reflects an azimuth angle of planes corresponding to the geological structure. The trajectory of the wellbore is changed in response to displaying the determined actual orientation of the geological structure relative to the trajectory. | 05-20-2010 |
J. Chris Bristow, North Palm Beach, FL US
Patent application number | Description | Published |
---|---|---|
20130097162 | Method and system for generating and presenting search results that are based on location-based information from social networks, media, the internet, and/or actual on-site location - Method and system for generating and presenting search results that are based on location-based information from social networks, media, the internet, and/or actual on-site location. | 04-18-2013 |
Joseph Bristow, Lafayette, LA US
Patent application number | Description | Published |
---|---|---|
20130331557 | CHITOSAN MANUFACTURING PROCESS - A method for producing chitosan from naturally occurring chitin-containing raw material, such as crustacean shells, includes an optional pretreatment step to remove non-chitin rich organic material for example, shrimp flesh, from the raw material, e.g., shrimp shells. The optional pretreatment is followed by a demineralization step utilizing a mild hydrochloric acid solution and a deproteination step utilizing a mild sodium hydroxide solution. The deproteination step is followed by a deacetylation step to remove the acetyl group from N-acetylglucosamine (chitin) to form an amine group, yielding d-glucosamine (chitosan). Each step is followed by a washing step and the product is dried, preferably at a temperature not in excess of about 65° C. Known purification and grinding steps may also be used to produce the final chitosan product. The process is carried out in equipment comprising a series of substantially identical or similar tanks ( | 12-12-2013 |
20140378413 | HEMOSTATIC AGENTS AND METHODS OF USE - Modified chitosan hemostatic agents include reverse micelles ( | 12-25-2014 |
Joseph Bristow, Goose Creek, SC US
Patent application number | Description | Published |
---|---|---|
20090239084 | CHITOSAN-COATED HYDROPHOBIC GLASS AND METHOD OF MAKING - Glass surfaces, for example, windshield surfaces, have a durable hydrophobic coating applied thereto. The glass surface is first treated by any suitable method to enhance the ability of a chitosan polymer coating to durably or substantially permanently adhere thereto. Once the chitosan coating has been applied to the glass surface, the normally hydrophilic chitosan coating is rendered hydrophobic by suitable treatment, for example, by a combination of enzymatic and chemical treatments. Alternatively, the chitosan may be rendered hydrophobic prior to coating it on the glass surface, but that is a less preferred technique. The method of the invention provides a glass article having a hydrophobic surface. | 09-24-2009 |
20090275745 | CHITOSAN MANUFACTURING PROCESS - A method for producing chitosan from naturally occurring chitin-containing raw material, such as crustacean shells, includes an optional pretreatment step to remove non-chitin rich organic material for example, shrimp flesh, from the raw material, e.g., shrimp shells. The optional pretreatment is followed by a demineralization step utilizing a mild hydrochloric acid solution and a deproteination step utilizing a mild sodium hydroxide solution. The deproteination step is followed by a deacetylation step to remove the acetyl group from N-acetylglucosamine (chitin) to form an amine group, yielding d-glucosamine (chitosan). Each step is followed by a washing step and the product is dried, preferably at a temperature not in excess of about 65° C. Known purification and grinding steps may also be used to produce the final chitosan product. The process is carried out in equipment comprising a series of substantially identical or similar tanks ( | 11-05-2009 |
Joseph F. Bristow, Lafayette, LA US
Patent application number | Description | Published |
---|---|---|
20140314825 | CHITOSAN DENTAL SURGICAL MEMBRANE AND METHOD OF MAKING - A porous, resorbable and flexible dental surgical membrane ( | 10-23-2014 |
20140336147 | HEMOSTATIC AGENTS AND METHODS OF USE - Modified chitosan hemostatic agents include reverse micelles ( | 11-13-2014 |
Lorin Brooks Bristow, Franklin, TN US
Patent application number | Description | Published |
---|---|---|
20090077191 | SYSTEM AND METHOD FOR DISTRIBUTING NOTIFICATIONS TO A GROUP OF RECIPIENTS - Systems and methods by which a user may use a client computing device (such as a mobile phone, for example) to initiate and send a notification message to a selected group of recipients are provided. The notification message may be an audio message that is delivered by various electronic methods including e-mail, text message, and/or voicemail. In defining the notification message, the user is provided with the ability to request a confirmation that the notification message has been received and/or understood by the selected recipients. In some embodiments, recipients are asked to respond to the notification message indicating that they have received and understood the message. | 03-19-2009 |
Michael Bristow, Englewood, CO US
Patent application number | Description | Published |
---|---|---|
20080227844 | Methods for Treatment with Bucindolol Based on Genetic Targeting - The present invention concerns the use of methods for evaluating bucindolol treatment for a patient, particularly one with heart failure. It concerns methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient is homozygous for the Arg 389 polymorphism in the β1-adrenergic receptor (AR). | 09-18-2008 |
20120289573 | METHODS FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC TARGETING - The present invention concerns the use of methods for evaluating bucindolol treatment for a patient, particularly one with heart failure. It concerns methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient is homozygous for the Arg 389 polymorphism in the β1-adrenergic receptor (AR). | 11-15-2012 |
20130203827 | POLYMORPHISMS IN THE PDE3A GENE - Embodiments of the invention are directed to identifying or treating a patient that would benefit from phosphodiesterase inhibitor therapy. | 08-08-2013 |
20150276717 | METHODS FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC TARGETING - The present invention concerns the use of methods for evaluating bucindolol treatment for a patient, particularly one with heart failure. It concerns methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient is homozygous for the Arg 389 polymorphism in the β1-adrenergic receptor (AR). | 10-01-2015 |
Michael R. Bristow, Cherry Hills Village, CO US
Patent application number | Description | Published |
---|---|---|
20100267804 | DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS - The present invention discloses specific miRNAs as novel biomarkers and therapeutic targets in the treatment of heart failure. Methods of treating or preventing heart failure in a subject by administering mimics or inhibitors of these particular miRNAs are disclosed. A method of diagnosing or prognosing heart failure in a subject by determining the level of expression of one or more miRNAs is also described. | 10-21-2010 |
20150141495 | DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS - The present invention discloses specific miRNAs as novel biomarkers and therapeutic targets in the treatment of heart failure. Methods of treating or preventing heart failure in a subject by administering mimics or inhibitors of these particular miRNAs are disclosed. A method of diagnosing or prognosing heart failure in a subject by determining the level of expression of one or more miRNAs is also described. | 05-21-2015 |
Michael R. Bristow, Englewood, CO US
Patent application number | Description | Published |
---|---|---|
20090220507 | INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE - The present invention provides for methods of treating and preventing cardiac hypertrophy and heart failure. The present invention provides the link between ERK1/2 and calcineurin and CamKII. The present invention further demonstrates that inhibitors of ERK1/2 inhibit cardiac hypertrophy and heart disease by inhibiting, in part, the fetal cardiac gene expression that occurs when Ca2+-dependent signalling occurs in the heart. | 09-03-2009 |
20120108617 | METHODS AND COMPOSITIONS INVOLVING (S)-BUCINDOLOL - Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of its R-stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Also disclosed are methods of treating a patient that involve administering to the patient a therapeutically effective amount of a composition of the present invention. Formula (I). | 05-03-2012 |
20130131161 | METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS - Embodiments of the invention are directed to identifying or treating a patient that would benefit from phosphodiesterase inhibitor therapy. | 05-23-2013 |
20130310436 | METHODS FOR PREDICTING RESPONSE TO BETA-BLOCKER THERAPY IN NON-ISCHEMIC HEART FAILURE PATIENTS - The present invention provides methods and apparatuses for predicting mortality and determining the likelihood of success of β-blocker therapy in a patient who has suffered non-ischemic heart failure as well as providing probability of short-term and/or long term survival rate of a non-ischemic heart failure patient. In addition, the present invention provides a method for determining a treatment procedure for a non-ischemic heart failure patient. | 11-21-2013 |
20150190375 | METHODS AND COMPOSITIONS INVOLVING (S)-BUCINDOLOL - Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of its R-stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Also disclosed are methods of treating a patient that involve administering to the patient a therapeutically effective amount of a composition of the present invention. | 07-09-2015 |
Robert E. Bristow, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20120035414 | CONTOURED ELASTOMERIC BARRIER FOR BOWEL RETENTION AND METHOD OF USE - The invention provides a device for bowel packing having an essentially elliptical shape that is essentially symmetrical along a minor axis of the ellipse, and the device includes a notch located on the minor axis below the major axis. The device is composed of material comprising an elastomeric polymer and the device is appropriately sized for retaining the intestines of a mammal. The invention further provides methods of use of the devices of the invention for bowel packing. The invention further provides methods for increasing bowel packing speed, increasing effectiveness of bowel retention, decreasing the formation of post-operative intraperitoneal adhesions, and increasing temperature of the abdominal cavity during surgery by use of the device. | 02-09-2012 |
Stephen D. Bristow, Los Altos Hills, CA US
Patent application number | Description | Published |
---|---|---|
20080303903 | Networked video surveillance system - A method of storing and accessing surveillance camera video data is provided. Captured video data as well as corresponding metadata is stored, at least temporarily, at the user sites. Additionally, the metadata and at least a portion of the video data is transmitted to a remotely located third party site where it is stored. The user server systems located at the independent user sites are connected to the third party server system via the Internet. Parties having data access rights, i.e., validated users, access the data stored at the third party site using Internet connected secondary computer systems. | 12-11-2008 |
Stephen Dixon Bristow, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20110123971 | Electronic Medical Voice Instruction System - An audible medical information system for a patient or other lay user that is loaded with content by a company or the health care practitioner and can be played at will by the patient and a means for recording information in the audio file. In one embodiment, the system records information in a physical card that the user can have with them without the need for any electronic devices such as a computer or smart phone. Other embodiments may include electronic audio or video files delivered to a computer or smart phone. The audio file can contain up to several minutes of audible information, some of which may be patient specific and some of which may be disease or medication specific. The information may include pre- or post-surgical instructions, information about medications or basic use instructions for medical devices. | 05-26-2011 |
20120178063 | Health/Wellness Appliance - A simple, low cost device to communicate important information about a change in state relative to someone's health or wellness, ie recovery from surgery or illness. This invention focuses on the delivery of such information in audio (or video) format, tailored to the language needs of the patient or caregiver, in a simple, intuitive device that the user can access any time to hear the appropriate message. | 07-12-2012 |
Stephen G. Bristow, Waterford, MI US
Patent application number | Description | Published |
---|---|---|
20090125318 | SYSTEM AND METHOD OF PROVIDING MARKETING PRODUCTION - A method of providing marketing products to a user includes storing the marketing products in a data storage device. The marketing products are categorized such that each marketing product is associated with at least one category. A graphic is divided into a plurality of categories and displayed to the user via a display. Each category is selectable by the user using an input device. In response to a category being selected by the user, a list of marketing products is presented to the user via the display. The list corresponds to the category selected by the user. A selection from the user of one of the marketing products presented on the list is received via the input device. In response to the selection of the marketing product, the marketing product is sent to the user. | 05-14-2009 |
Steven R. Bristow, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20100066448 | DEVICE UNDER TEST POWER SUPPLY - A power supply with and input and output includes an amplifier configured to set an output voltage of the power supply output equal to a fixed input voltage for the power supply. The power supply has a first output stage coupled to the amplifier and configured to source and sink current at the output of the power supply between a first voltage rail and a third voltage rail. The power supply has a second output stage coupled to the amplifier and configured to source and sink current to the output of the power supply between a second voltage rail and the third voltage rail. A selection device is configured to enable the first and second output stages based on a selection input signal. The selection device is situated outside of the first and the second output stages. | 03-18-2010 |
20110298483 | TESTER HAVING DEVICE UNDER TEST POWER SUPPLY - A tester includes a device under test (DUT) power supply (DPS) with and input and output includes an amplifier configured to set an output voltage of the DPS output equal to an input voltage for the DPS. The DPS has a first output stage coupled to the amplifier and configured to source and sink current at the output of the DPS between a first voltage rail and a third voltage rail. The | 12-08-2011 |